New York Presbyterian/Columbia University Medical Center
Apr 2011 to 2000 Technical Manager-Radiation OncologyAKSM Oncology Bloomfield, NJ Aug 2010 to Apr 2011 Center Manager / DosimetristCentral Vermont Medical Center Berlin, VT Aug 2009 to Aug 2010 DosimetristDartmouth-Hitchcock Medical Center Lebanon, NH Nov 2007 to Aug 2009 DosimetristSparta Cancer Center Sparta, NJ May 2003 to Nov 2007 Chief Radiation Therapy Technologist/Staff DosimetristBayonne Medical Center Bayonne, NJ Jan 2003 to May 2003 Chief Radiation Therapy TechnologistSt. Joseph's Hospital and Medical Center Paterson, NJ Dec 1997 to Jan 2003 Senior Radiation Therapy TechnologistGood Samaritan Hospital Suffern, NY Jan 1997 to Mar 1998 Radiologic Technologist/CT TechBeth Israel Hospital Passaic, NJ Sep 1996 to Feb 1997 Radiologic Technologist
South Jersey born and raised. Computer technician and website designer. Owner of MS Computer Services LLC and hostbythecoast.com website hosting and design services.
Tagline:
Owner of MS Computer Services LLC. Web Hosting and Web Design Company
Bragging Rights:
Single father of special needs son and he's a great kid.
Michael Schweizer
Work:
Mvg
Michael Schweizer
Tagline:
Genug!
Michael Schweizer
Michael Schweizer
Michael Schweizer
News
Testosterone therapy suppresses some advanced prostate cancers, find Johns ...
"This really is the most lethal form of prostate cancer," says Michael Schweizer, M.D., researcher at Fred Hutchinson Cancer Research Center and contributor to the study during his recent fellowship at Johns Hopkins. "It's the one that's the most resistant, and typically once people progress to this
Date: Jan 08, 2015
Category: Health
Source: Google
Strategy Might Thwart Resistance to a Common Prostate Cancer Treatment
SOURCES: Michael Schweizer, M.D., assistant professor, oncology, University of Washington School of Medicine, Seattle; Samuel Denmeade, M.D., co-director, prostate cancer program, Johns Hopkins University, Baltimore; Anthony D'Amico, M.D., Ph.D., chief, radiation oncology, Brigham and Women's Hospit
Date: Jan 07, 2015
Category: Health
Source: Google
Testosterone Fuel for Prostate Cancer Stalls Tumors in Surprise
This is really the most lethal form of prostate cancer,said Michael Schweizer, the studys lead researcher from FredHutchinson Cancer Research Center in Seattle. Once peopleprogress to this stage, its when we start to worry that theyreat a much higher risk for dying from prostate cancer.
Date: Jan 07, 2015
Category: Health
Source: Google
Cancer paradox: Testosterone injections combat lethal prostate tumors
Medical oncologist Michael Schweizer, now at the University of Washington, Seattle, and colleagues from the Johns Hopkins University School of Medicine in Baltimore, Maryland, tested this strategy in 16 men whose prostate cancers had become resistant to chemical castration. Most of their tumors had
Date: Jan 07, 2015
Category: Health
Source: Google
Strategy Might Thwart Resistance to a Common Prostate Cancer Treatment
confirmed in several ongoing larger trials, "this could lead to a new treatment approach" for prostate cancers that have grown resistant to hormonal therapy, said lead researcher Dr. Michael Schweizer, an assistant professor of oncology at the University of Washington School of Medicine in Seattle.